Georgia Erbez

2021 - Harpoon Therapeutics

In 2021, Georgia Erbez earned a total compensation of $2.2M as Former Chief Financial Officer at Harpoon Therapeutics, a 118% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$203,550
Option Awards$1,599,386
Salary$415,000
Other$9,711
Total$2,227,647

Erbez received $1.6M in option awards, accounting for 72% of the total pay in 2021.

Erbez also received $203.6K in non-equity incentive plan, $415K in salary and $9.7K in other compensation.

Rankings

In 2021, Georgia Erbez's compensation ranked 5,621st out of 12,412 executives tracked by ExecPay. In other words, Erbez earned more than 54.7% of executives.

ClassificationRankingPercentile
All
5,621
out of 12,412
55th
Division
Manufacturing
2,382
out of 5,498
57th
Major group
Chemicals And Allied Products
1,035
out of 2,374
56th
Industry group
Drugs
924
out of 2,095
56th
Industry
Biological Products, Except Diagnostic Substances
226
out of 452
50th
Source: SEC filing on April 27, 2023.

Erbez's colleagues

We found three more compensation records of executives who worked with Georgia Erbez at Harpoon Therapeutics in 2021.

2021

Natalie Sacks

Harpoon Therapeutics

Chief Medical Officer

2021

Julie Eastland

Harpoon Therapeutics

Chief Executive Officer

2021

Holger Wesche

Harpoon Therapeutics

Chief Scientific Officer

News

In-depth

You may also like